AMNEAL PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $4.01B
Liabilities Breakdown FY2020
Total Liabilities: $3.70B
Asset Breakdown
Total Assets: $4.01B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $341.4M | 8.5% |
| Accounts Receivable | $638.9M | 15.9% |
| Inventory | $490.6M | 12.2% |
| Property, Plant & Equipment | $477.8M | 11.9% |
| Goodwill | $522.8M | 13.1% |
| Intangible Assets | $1.30B | 32.6% |
| Other Assets | $229.9M | 5.7% |
Liabilities Breakdown
Total Liabilities: $3.70B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $153.1M | 4.1% |
| Long-Term Debt | $2.74B | 73.9% |
| Other Liabilities | $814.4M | 22.0% |